Onconetix ONCO 深 沪
已收盘 10-02 16:00:00 美东时间
0.7337
-0.010
-1.40%
华盛通- 最 高0.75
- 今 开0.7376
- 成交量 40.94万股
- 最 低 0.713
- 昨 收 0.7441
- 总市值 289.75万
- 52周最高 200.00
- 市盈率 静 --
- 换手率 10.37%
- 52周最低 0.5859
- 委 比 96.28%
- 总股本 394.91万
- 历史最高 15453000.00
- 量 比 0.03
- 振 幅 4.97%
- 历史最低 0.713
- 每 手 1
- 风险率 59.52%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)
SRX Global Inc. has updated shareholders on the liquidation of Vistagen Therapeutics and Greenland Mines, and added an investment in Onconetix Inc. (ONCO) in anticipation of its acquisition of Realbotix LLC. Realbotix's Vinci AI Vision System, featuring robotic eyeballs with embedded cameras and tracking lenses, enables facial recognition, object detection, and emotional analysis. SRX believes the technology is undervalued and has significant pot...
09-24 16:30
Onconetix shares are trading lower. The company announced a strategic bridge financing facility of up to $5 million to Realbotix.
Onconetix shares are trading lower. The company announced a strategic bridge financing facility of up to $5 million to Realbotix.
09-15 01:23
Onconetix Secures Bridge Financing for Realbotix Acquisition
An update from Onconetix ( ($ONCO) ) is now available. On September 11, 2026, O...
09-14 23:17
CORRECTED: Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition
Onconetix, Inc. has provided a $5 million strategic bridge financing facility to Realbotix LLC, with an initial $2.5 million advance, to support its growth and working capital needs. The non-interest-bearing facility will be automatically canceled upon closing of the pending acquisition. The acquisition, announced in February 2026, involves Onconetix acquiring 100% of Realbotix's equity in an all-stock transaction, subject to shareholder approval...
09-14 16:50
Onconetix shares are trading lower after the company announced a 1-for-10 reverse stock split.
Onconetix shares are trading lower after the company announced a 1-for-10 rever...
05-19 20:49
UPDATED: Onconetix Announces 1-For-10 Reverse Stock Split, Effective May 21, 2026
Onconetix, Inc. (NASDAQ:ONCO) ("Onconetix" or the "Company"), a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for oncology, today announced
05-19 20:43
Why Agilysys Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
Agilysys Inc (AGYS) shares rose in pre-market trading after reporting better-than-expected financial results and issuing positive sales guidance. Other notable gainers and losers in pre-market trading include AMST, HAO, MTVA, ONCO, SDA, PIII, VRAX, PURR, BKKT, WOK, BTM, and UBXG.
05-19 16:47
Onconetix Q1 EPS $(6.71) Up From $(225.25) YoY, Sales $21.457K Down From $101.630K YoY
Onconetix (NASDAQ:ONCO) reported quarterly losses of $(6.71) per share. This is a 97.02 percent increase over losses of $(225.25) per share from the same period last year. The company reported $21.457 thousand in sales
05-13 21:48
